Scientists reported that targeting the Notch ligand Jagged1 by a monoclonal antibody reduced neovascular lesion size, number of activated phagocytes and inflammatory markers, and vascular leakage in an experimental choroidal neovascularization mouse model.
[Nature Communications]
